Bausch and Lomb Launches New IOL to Treat Cataracts

Bausch and Lomb has just released the Crystalens Aspheric Optic (AO), a lens to be used in the treatment of cataracts. The new Crystalens AO is the first aberration-free accommodating intraocular lens with aspheric optics.

A primary benefit of this product is that it enhances retinal image quality without sacrificing depth of field. Bausch and Lomb executives have released statements claiming that the Crystalens AO will soon become a leader in cataract treatment technology.

Cataracts are one of the most common age-related visual disorders affecting Americans today. As part of the aging process, the proteins in your eye's lens may deteriorate and clump together, forming cataracts. The result is a clouding of your eye's lens which reduces the amount of light that hits the retina.

If untreated, cataracts will eventually lead to blindness. The condition can be treated through cataract surgery, which generally involves removing your damaged lens and replacing it with an artificial intraocular lens. The new Crystalens AO from Bausch and Lomb is the latest IOL to be released for use in cataract surgery.

Please contact the LASIK Directory today to find a qualified ophthalmologist in your area.